These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20410516)

  • 1. Advances in the development of vaccines against Neisseria meningitidis.
    Tan LK; Carlone GM; Borrow R
    N Engl J Med; 2010 Apr; 362(16):1511-20. PubMed ID: 20410516
    [No Abstract]   [Full Text] [Related]  

  • 2. Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?
    Gorringe AR
    Expert Rev Vaccines; 2005 Jun; 4(3):373-9. PubMed ID: 16026250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal disease.
    Rosenstein NE; Perkins BA; Stephens DS; Popovic T; Hughes JM
    N Engl J Med; 2001 May; 344(18):1378-88. PubMed ID: 11333996
    [No Abstract]   [Full Text] [Related]  

  • 6. Meningococcal vaccines.
    Danzig L
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in vaccines to prevent meningococcal serogroup B infections.
    Vermont CL; van den Dobbelsteen GP; de Groot R
    Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel antigens that protect against systemic meningococcal infection.
    Sun Y; Li Y; Exley RM; Winterbotham M; Ison C; Smith H; Tang CM
    Vaccine; 2005 Jul; 23(32):4136-41. PubMed ID: 15964482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against meningococcal disease: current and future technologies.
    Riddell A; Buttery J
    Expert Opin Biol Ther; 2001 May; 1(3):385-99. PubMed ID: 11727513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
    Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
    Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for the poor: meningococcal A conjugate vaccine in Africa.
    Isaacs D
    J Paediatr Child Health; 2011 Jan; 47(1-2):66. PubMed ID: 21255149
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks.
    Taha MK; Zarantonelli ML; Alonso JM; Naess LM; Holst J; Feiring B; Rosenqvist E
    Vaccine; 2007 Mar; 25(14):2537-8. PubMed ID: 16460845
    [No Abstract]   [Full Text] [Related]  

  • 13. Meningococcal vaccines.
    Poolman JT
    J Med Microbiol; 1988 Jul; 26(3):170-2. PubMed ID: 3134548
    [No Abstract]   [Full Text] [Related]  

  • 14. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 15. Meningococcal protein antigens and vaccines.
    Feavers IM; Pizza M
    Vaccine; 2009 Jun; 27 Suppl 2():B42-50. PubMed ID: 19481315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
    Trotter CL; Ramsay ME
    FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
    Alonso JM; Gilmet G; Rouzic EM; Nassif X; Plotkin SA; Ramsay M; Siegrist CA; Stephens DS; Teyssou R; Vogel U
    Vaccine; 2007 May; 25(21):4125-9. PubMed ID: 17449149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer-membrane-vesicle vaccines: old but not forgotten.
    Stephens DS
    Lancet Infect Dis; 2011 Jun; 11(6):421-2. PubMed ID: 21489883
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions between Neisseria meningitidis and the complement system.
    Schneider MC; Exley RM; Ram S; Sim RB; Tang CM
    Trends Microbiol; 2007 May; 15(5):233-40. PubMed ID: 17398100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease transmission: routes, contributing factors and herd immunity.
    O'Brien K
    Int J Clin Pract Suppl; 2001 Feb; (118):5-7. PubMed ID: 11715363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.